{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.31 vs. cons $5.29",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.11B vs. cons $2.10B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "MISS",
      "answer": "pred ~4.0% vs. cons 4.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted diluted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$21.93 vs. cons $21.90 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 total revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~8.0% vs. cons 8.1% (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 organic revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.5% vs. cons 5.5% (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.75,
  "day5_path": "FADE",
  "day5_rationale": "A clean EPS/revenue result and preserved FY26 outlook (~$21.93 vs. cons $21.90) should produce an initial relief move, but the softer organic result (~4.0% vs. cons 4.5%) and unchanged 5.5% organic-growth framework leave little out-period estimate upside.",
  "day5_confidence": "MEDIUM"
}